nodes	percent_of_prediction	percent_of_DWPC	metapath
Glimepiride—Gliclazide—VEGFA—pancreatic cancer	0.0121	0.565	CrCbGaD
Glimepiride—Glipizide—PPARG—pancreatic cancer	0.00931	0.435	CrCbGaD
Glimepiride—Menopausal symptoms—Doxorubicin—pancreatic cancer	0.00153	0.00156	CcSEcCtD
Glimepiride—Anorexia—Gemcitabine—pancreatic cancer	0.00153	0.00156	CcSEcCtD
Glimepiride—Dizziness—Erlotinib—pancreatic cancer	0.00153	0.00156	CcSEcCtD
Glimepiride—Erythema multiforme—Docetaxel—pancreatic cancer	0.00151	0.00155	CcSEcCtD
Glimepiride—Dermatitis bullous—Doxorubicin—pancreatic cancer	0.00151	0.00154	CcSEcCtD
Glimepiride—Anorexia—Fluorouracil—pancreatic cancer	0.0015	0.00153	CcSEcCtD
Glimepiride—Hypotension—Gemcitabine—pancreatic cancer	0.0015	0.00153	CcSEcCtD
Glimepiride—Insomnia—Irinotecan—pancreatic cancer	0.00149	0.00152	CcSEcCtD
Glimepiride—Vomiting—Tamoxifen—pancreatic cancer	0.00148	0.00151	CcSEcCtD
Glimepiride—Hypoglycaemia—Doxorubicin—pancreatic cancer	0.00148	0.00151	CcSEcCtD
Glimepiride—Paraesthesia—Irinotecan—pancreatic cancer	0.00148	0.00151	CcSEcCtD
Glimepiride—Cerebrovascular accident—Doxorubicin—pancreatic cancer	0.00147	0.00151	CcSEcCtD
Glimepiride—Hypotension—Fluorouracil—pancreatic cancer	0.00147	0.0015	CcSEcCtD
Glimepiride—Hypersensitivity—Sunitinib—pancreatic cancer	0.00147	0.0015	CcSEcCtD
Glimepiride—Rash—Tamoxifen—pancreatic cancer	0.00147	0.0015	CcSEcCtD
Glimepiride—Dermatitis—Tamoxifen—pancreatic cancer	0.00147	0.0015	CcSEcCtD
Glimepiride—Vomiting—Erlotinib—pancreatic cancer	0.00147	0.0015	CcSEcCtD
Glimepiride—Dyspnoea—Irinotecan—pancreatic cancer	0.00147	0.0015	CcSEcCtD
Glimepiride—Somnolence—Irinotecan—pancreatic cancer	0.00146	0.00149	CcSEcCtD
Glimepiride—Headache—Tamoxifen—pancreatic cancer	0.00146	0.00149	CcSEcCtD
Glimepiride—Rash—Erlotinib—pancreatic cancer	0.00145	0.00149	CcSEcCtD
Glimepiride—Dermatitis—Erlotinib—pancreatic cancer	0.00145	0.00148	CcSEcCtD
Glimepiride—Hyponatraemia—Doxorubicin—pancreatic cancer	0.00145	0.00148	CcSEcCtD
Glimepiride—Insomnia—Gemcitabine—pancreatic cancer	0.00145	0.00148	CcSEcCtD
Glimepiride—Dyspepsia—Irinotecan—pancreatic cancer	0.00145	0.00148	CcSEcCtD
Glimepiride—Headache—Erlotinib—pancreatic cancer	0.00144	0.00148	CcSEcCtD
Glimepiride—Pain in extremity—Doxorubicin—pancreatic cancer	0.00144	0.00148	CcSEcCtD
Glimepiride—Paraesthesia—Gemcitabine—pancreatic cancer	0.00144	0.00147	CcSEcCtD
Glimepiride—Asthenia—Sunitinib—pancreatic cancer	0.00143	0.00146	CcSEcCtD
Glimepiride—Decreased appetite—Irinotecan—pancreatic cancer	0.00143	0.00146	CcSEcCtD
Glimepiride—Arrhythmia—Docetaxel—pancreatic cancer	0.00143	0.00146	CcSEcCtD
Glimepiride—Dyspnoea—Gemcitabine—pancreatic cancer	0.00143	0.00146	CcSEcCtD
Glimepiride—Insomnia—Fluorouracil—pancreatic cancer	0.00142	0.00146	CcSEcCtD
Glimepiride—Somnolence—Gemcitabine—pancreatic cancer	0.00142	0.00146	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.00142	0.00145	CcSEcCtD
Glimepiride—Fatigue—Irinotecan—pancreatic cancer	0.00142	0.00145	CcSEcCtD
Glimepiride—Paraesthesia—Fluorouracil—pancreatic cancer	0.00141	0.00145	CcSEcCtD
Glimepiride—Pruritus—Sunitinib—pancreatic cancer	0.00141	0.00144	CcSEcCtD
Glimepiride—Dyspnoea—Fluorouracil—pancreatic cancer	0.0014	0.00143	CcSEcCtD
Glimepiride—Somnolence—Fluorouracil—pancreatic cancer	0.0014	0.00143	CcSEcCtD
Glimepiride—Malnutrition—Docetaxel—pancreatic cancer	0.00139	0.00142	CcSEcCtD
Glimepiride—Erythema—Docetaxel—pancreatic cancer	0.00139	0.00142	CcSEcCtD
Glimepiride—Decreased appetite—Gemcitabine—pancreatic cancer	0.00139	0.00142	CcSEcCtD
Glimepiride—Dyspepsia—Fluorouracil—pancreatic cancer	0.00139	0.00142	CcSEcCtD
Glimepiride—Nausea—Tamoxifen—pancreatic cancer	0.00138	0.00141	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.00138	0.00141	CcSEcCtD
Glimepiride—Fatigue—Gemcitabine—pancreatic cancer	0.00138	0.00141	CcSEcCtD
Glimepiride—Alanine aminotransferase increased—Epirubicin—pancreatic cancer	0.00138	0.00141	CcSEcCtD
Glimepiride—Nausea—Erlotinib—pancreatic cancer	0.00137	0.0014	CcSEcCtD
Glimepiride—Decreased appetite—Fluorouracil—pancreatic cancer	0.00137	0.0014	CcSEcCtD
Glimepiride—Diarrhoea—Sunitinib—pancreatic cancer	0.00137	0.0014	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.00136	0.00139	CcSEcCtD
Glimepiride—Abdominal distension—Epirubicin—pancreatic cancer	0.00136	0.00139	CcSEcCtD
Glimepiride—Feeling abnormal—Irinotecan—pancreatic cancer	0.00136	0.00138	CcSEcCtD
Glimepiride—Influenza—Epirubicin—pancreatic cancer	0.00135	0.00138	CcSEcCtD
Glimepiride—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.00134	0.00137	CcSEcCtD
Glimepiride—Eosinophilia—Epirubicin—pancreatic cancer	0.00134	0.00136	CcSEcCtD
Glimepiride—Dizziness—Sunitinib—pancreatic cancer	0.00132	0.00135	CcSEcCtD
Glimepiride—Feeling abnormal—Gemcitabine—pancreatic cancer	0.00132	0.00135	CcSEcCtD
Glimepiride—Angina pectoris—Epirubicin—pancreatic cancer	0.00131	0.00134	CcSEcCtD
Glimepiride—Abdominal pain—Irinotecan—pancreatic cancer	0.0013	0.00133	CcSEcCtD
Glimepiride—Feeling abnormal—Fluorouracil—pancreatic cancer	0.0013	0.00133	CcSEcCtD
Glimepiride—Anaemia—Docetaxel—pancreatic cancer	0.00129	0.00132	CcSEcCtD
Glimepiride—Pancytopenia—Epirubicin—pancreatic cancer	0.00128	0.00131	CcSEcCtD
Glimepiride—Alanine aminotransferase increased—Doxorubicin—pancreatic cancer	0.00127	0.0013	CcSEcCtD
Glimepiride—Vomiting—Sunitinib—pancreatic cancer	0.00127	0.0013	CcSEcCtD
Glimepiride—Rash—Sunitinib—pancreatic cancer	0.00126	0.00129	CcSEcCtD
Glimepiride—Dermatitis—Sunitinib—pancreatic cancer	0.00126	0.00129	CcSEcCtD
Glimepiride—Abdominal distension—Doxorubicin—pancreatic cancer	0.00126	0.00128	CcSEcCtD
Glimepiride—Urticaria—Fluorouracil—pancreatic cancer	0.00125	0.00128	CcSEcCtD
Glimepiride—Headache—Sunitinib—pancreatic cancer	0.00125	0.00128	CcSEcCtD
Glimepiride—Influenza—Doxorubicin—pancreatic cancer	0.00125	0.00127	CcSEcCtD
Glimepiride—Leukopenia—Docetaxel—pancreatic cancer	0.00125	0.00127	CcSEcCtD
Glimepiride—Pollakiuria—Epirubicin—pancreatic cancer	0.00125	0.00127	CcSEcCtD
Glimepiride—Eosinophilia—Doxorubicin—pancreatic cancer	0.00124	0.00126	CcSEcCtD
Glimepiride—Palpitations—Docetaxel—pancreatic cancer	0.00123	0.00126	CcSEcCtD
Glimepiride—Photosensitivity reaction—Epirubicin—pancreatic cancer	0.00123	0.00126	CcSEcCtD
Glimepiride—Weight increased—Epirubicin—pancreatic cancer	0.00123	0.00125	CcSEcCtD
Glimepiride—Loss of consciousness—Docetaxel—pancreatic cancer	0.00122	0.00125	CcSEcCtD
Glimepiride—Angina pectoris—Doxorubicin—pancreatic cancer	0.00122	0.00124	CcSEcCtD
Glimepiride—Hypersensitivity—Irinotecan—pancreatic cancer	0.00121	0.00124	CcSEcCtD
Glimepiride—Convulsion—Docetaxel—pancreatic cancer	0.00121	0.00123	CcSEcCtD
Glimepiride—Hypertension—Docetaxel—pancreatic cancer	0.0012	0.00123	CcSEcCtD
Glimepiride—Drowsiness—Epirubicin—pancreatic cancer	0.0012	0.00123	CcSEcCtD
Glimepiride—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	0.00119	0.00122	CcSEcCtD
Glimepiride—Nausea—Sunitinib—pancreatic cancer	0.00119	0.00121	CcSEcCtD
Glimepiride—Pancytopenia—Doxorubicin—pancreatic cancer	0.00118	0.00121	CcSEcCtD
Glimepiride—Asthenia—Irinotecan—pancreatic cancer	0.00118	0.00121	CcSEcCtD
Glimepiride—Jaundice—Epirubicin—pancreatic cancer	0.00117	0.0012	CcSEcCtD
Glimepiride—Hypersensitivity—Fluorouracil—pancreatic cancer	0.00116	0.00119	CcSEcCtD
Glimepiride—Dry mouth—Docetaxel—pancreatic cancer	0.00116	0.00119	CcSEcCtD
Glimepiride—Sweating—Epirubicin—pancreatic cancer	0.00115	0.00118	CcSEcCtD
Glimepiride—Pollakiuria—Doxorubicin—pancreatic cancer	0.00115	0.00118	CcSEcCtD
Glimepiride—Asthenia—Gemcitabine—pancreatic cancer	0.00115	0.00117	CcSEcCtD
Glimepiride—Confusional state—Docetaxel—pancreatic cancer	0.00115	0.00117	CcSEcCtD
Glimepiride—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.00114	0.00116	CcSEcCtD
Glimepiride—Anaphylactic shock—Docetaxel—pancreatic cancer	0.00114	0.00116	CcSEcCtD
Glimepiride—Weight increased—Doxorubicin—pancreatic cancer	0.00114	0.00116	CcSEcCtD
Glimepiride—Pruritus—Gemcitabine—pancreatic cancer	0.00113	0.00116	CcSEcCtD
Glimepiride—Diarrhoea—Irinotecan—pancreatic cancer	0.00113	0.00115	CcSEcCtD
Glimepiride—Agranulocytosis—Epirubicin—pancreatic cancer	0.00112	0.00115	CcSEcCtD
Glimepiride—Shock—Docetaxel—pancreatic cancer	0.00112	0.00114	CcSEcCtD
Glimepiride—Pruritus—Fluorouracil—pancreatic cancer	0.00111	0.00114	CcSEcCtD
Glimepiride—Thrombocytopenia—Docetaxel—pancreatic cancer	0.00111	0.00114	CcSEcCtD
Glimepiride—Drowsiness—Doxorubicin—pancreatic cancer	0.00111	0.00114	CcSEcCtD
Glimepiride—Tachycardia—Docetaxel—pancreatic cancer	0.00111	0.00113	CcSEcCtD
Glimepiride—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.0011	0.00113	CcSEcCtD
Glimepiride—Bradycardia—Epirubicin—pancreatic cancer	0.0011	0.00112	CcSEcCtD
Glimepiride—Diarrhoea—Gemcitabine—pancreatic cancer	0.0011	0.00112	CcSEcCtD
Glimepiride—Dizziness—Irinotecan—pancreatic cancer	0.00109	0.00111	CcSEcCtD
Glimepiride—Jaundice—Doxorubicin—pancreatic cancer	0.00108	0.00111	CcSEcCtD
Glimepiride—Anorexia—Docetaxel—pancreatic cancer	0.00108	0.00111	CcSEcCtD
Glimepiride—Hepatitis—Epirubicin—pancreatic cancer	0.00108	0.0011	CcSEcCtD
Glimepiride—Diarrhoea—Fluorouracil—pancreatic cancer	0.00108	0.0011	CcSEcCtD
Glimepiride—Sweating—Doxorubicin—pancreatic cancer	0.00107	0.00109	CcSEcCtD
Glimepiride—Hypotension—Docetaxel—pancreatic cancer	0.00106	0.00109	CcSEcCtD
Glimepiride—Vomiting—Irinotecan—pancreatic cancer	0.00105	0.00107	CcSEcCtD
Glimepiride—Dizziness—Fluorouracil—pancreatic cancer	0.00104	0.00106	CcSEcCtD
Glimepiride—Visual impairment—Epirubicin—pancreatic cancer	0.00104	0.00106	CcSEcCtD
Glimepiride—Agranulocytosis—Doxorubicin—pancreatic cancer	0.00104	0.00106	CcSEcCtD
Glimepiride—Rash—Irinotecan—pancreatic cancer	0.00104	0.00106	CcSEcCtD
Glimepiride—Dermatitis—Irinotecan—pancreatic cancer	0.00104	0.00106	CcSEcCtD
Glimepiride—Headache—Irinotecan—pancreatic cancer	0.00103	0.00105	CcSEcCtD
Glimepiride—Insomnia—Docetaxel—pancreatic cancer	0.00103	0.00105	CcSEcCtD
Glimepiride—Paraesthesia—Docetaxel—pancreatic cancer	0.00102	0.00104	CcSEcCtD
Glimepiride—Erythema multiforme—Epirubicin—pancreatic cancer	0.00102	0.00104	CcSEcCtD
Glimepiride—Vomiting—Gemcitabine—pancreatic cancer	0.00102	0.00104	CcSEcCtD
Glimepiride—Bradycardia—Doxorubicin—pancreatic cancer	0.00102	0.00104	CcSEcCtD
Glimepiride—Dyspnoea—Docetaxel—pancreatic cancer	0.00101	0.00104	CcSEcCtD
Glimepiride—Somnolence—Docetaxel—pancreatic cancer	0.00101	0.00103	CcSEcCtD
Glimepiride—Rash—Gemcitabine—pancreatic cancer	0.00101	0.00103	CcSEcCtD
Glimepiride—Dermatitis—Gemcitabine—pancreatic cancer	0.00101	0.00103	CcSEcCtD
Glimepiride—Headache—Gemcitabine—pancreatic cancer	0.001	0.00103	CcSEcCtD
Glimepiride—Vomiting—Fluorouracil—pancreatic cancer	0.001	0.00102	CcSEcCtD
Glimepiride—Dyspepsia—Docetaxel—pancreatic cancer	0.001	0.00102	CcSEcCtD
Glimepiride—Hepatitis—Doxorubicin—pancreatic cancer	0.000999	0.00102	CcSEcCtD
Glimepiride—Rash—Fluorouracil—pancreatic cancer	0.000993	0.00101	CcSEcCtD
Glimepiride—Dermatitis—Fluorouracil—pancreatic cancer	0.000992	0.00101	CcSEcCtD
Glimepiride—Decreased appetite—Docetaxel—pancreatic cancer	0.000988	0.00101	CcSEcCtD
Glimepiride—Headache—Fluorouracil—pancreatic cancer	0.000987	0.00101	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000981	0.001	CcSEcCtD
Glimepiride—Fatigue—Docetaxel—pancreatic cancer	0.00098	0.001	CcSEcCtD
Glimepiride—Nausea—Irinotecan—pancreatic cancer	0.000977	0.000998	CcSEcCtD
Glimepiride—Arrhythmia—Epirubicin—pancreatic cancer	0.000964	0.000985	CcSEcCtD
Glimepiride—Visual impairment—Doxorubicin—pancreatic cancer	0.000962	0.000983	CcSEcCtD
Glimepiride—Nausea—Gemcitabine—pancreatic cancer	0.000952	0.000972	CcSEcCtD
Glimepiride—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000944	0.000965	CcSEcCtD
Glimepiride—Malnutrition—Epirubicin—pancreatic cancer	0.00094	0.00096	CcSEcCtD
Glimepiride—Erythema—Epirubicin—pancreatic cancer	0.00094	0.00096	CcSEcCtD
Glimepiride—Feeling abnormal—Docetaxel—pancreatic cancer	0.000937	0.000957	CcSEcCtD
Glimepiride—Nausea—Fluorouracil—pancreatic cancer	0.000936	0.000956	CcSEcCtD
Glimepiride—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.00093	0.00095	CcSEcCtD
Glimepiride—Tension—Epirubicin—pancreatic cancer	0.000922	0.000942	CcSEcCtD
Glimepiride—Nervousness—Epirubicin—pancreatic cancer	0.000913	0.000933	CcSEcCtD
Glimepiride—Abdominal pain—Docetaxel—pancreatic cancer	0.000899	0.000918	CcSEcCtD
Glimepiride—Arrhythmia—Doxorubicin—pancreatic cancer	0.000892	0.000912	CcSEcCtD
Glimepiride—Vision blurred—Epirubicin—pancreatic cancer	0.000885	0.000905	CcSEcCtD
Glimepiride—Erythema—Doxorubicin—pancreatic cancer	0.000869	0.000888	CcSEcCtD
Glimepiride—Malnutrition—Doxorubicin—pancreatic cancer	0.000869	0.000888	CcSEcCtD
Glimepiride—Anaemia—Epirubicin—pancreatic cancer	0.000868	0.000887	CcSEcCtD
Glimepiride—Agitation—Epirubicin—pancreatic cancer	0.000863	0.000882	CcSEcCtD
Glimepiride—Tension—Doxorubicin—pancreatic cancer	0.000853	0.000872	CcSEcCtD
Glimepiride—Nervousness—Doxorubicin—pancreatic cancer	0.000844	0.000863	CcSEcCtD
Glimepiride—Leukopenia—Epirubicin—pancreatic cancer	0.000841	0.000859	CcSEcCtD
Glimepiride—Hypersensitivity—Docetaxel—pancreatic cancer	0.000838	0.000856	CcSEcCtD
Glimepiride—Palpitations—Epirubicin—pancreatic cancer	0.00083	0.000848	CcSEcCtD
Glimepiride—Loss of consciousness—Epirubicin—pancreatic cancer	0.000826	0.000844	CcSEcCtD
Glimepiride—Vision blurred—Doxorubicin—pancreatic cancer	0.000819	0.000837	CcSEcCtD
Glimepiride—Asthenia—Docetaxel—pancreatic cancer	0.000816	0.000834	CcSEcCtD
Glimepiride—Convulsion—Epirubicin—pancreatic cancer	0.000814	0.000832	CcSEcCtD
Glimepiride—Hypertension—Epirubicin—pancreatic cancer	0.000811	0.000829	CcSEcCtD
Glimepiride—Pruritus—Docetaxel—pancreatic cancer	0.000804	0.000822	CcSEcCtD
Glimepiride—Anaemia—Doxorubicin—pancreatic cancer	0.000803	0.000821	CcSEcCtD
Glimepiride—Agitation—Doxorubicin—pancreatic cancer	0.000799	0.000816	CcSEcCtD
Glimepiride—Anxiety—Epirubicin—pancreatic cancer	0.000797	0.000815	CcSEcCtD
Glimepiride—Dry mouth—Epirubicin—pancreatic cancer	0.000782	0.000799	CcSEcCtD
Glimepiride—Leukopenia—Doxorubicin—pancreatic cancer	0.000778	0.000795	CcSEcCtD
Glimepiride—Diarrhoea—Docetaxel—pancreatic cancer	0.000778	0.000795	CcSEcCtD
Glimepiride—Confusional state—Epirubicin—pancreatic cancer	0.000773	0.00079	CcSEcCtD
Glimepiride—Palpitations—Doxorubicin—pancreatic cancer	0.000768	0.000785	CcSEcCtD
Glimepiride—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000767	0.000784	CcSEcCtD
Glimepiride—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000764	0.000781	CcSEcCtD
Glimepiride—Shock—Epirubicin—pancreatic cancer	0.000754	0.000771	CcSEcCtD
Glimepiride—Convulsion—Doxorubicin—pancreatic cancer	0.000753	0.00077	CcSEcCtD
Glimepiride—Dizziness—Docetaxel—pancreatic cancer	0.000752	0.000768	CcSEcCtD
Glimepiride—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000751	0.000767	CcSEcCtD
Glimepiride—Hypertension—Doxorubicin—pancreatic cancer	0.000751	0.000767	CcSEcCtD
Glimepiride—Tachycardia—Epirubicin—pancreatic cancer	0.000748	0.000765	CcSEcCtD
Glimepiride—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000741	0.000758	CcSEcCtD
Glimepiride—Anxiety—Doxorubicin—pancreatic cancer	0.000738	0.000754	CcSEcCtD
Glimepiride—Anorexia—Epirubicin—pancreatic cancer	0.000731	0.000747	CcSEcCtD
Glimepiride—Dry mouth—Doxorubicin—pancreatic cancer	0.000724	0.00074	CcSEcCtD
Glimepiride—Vomiting—Docetaxel—pancreatic cancer	0.000723	0.000739	CcSEcCtD
Glimepiride—Rash—Docetaxel—pancreatic cancer	0.000717	0.000732	CcSEcCtD
Glimepiride—Hypotension—Epirubicin—pancreatic cancer	0.000717	0.000732	CcSEcCtD
Glimepiride—Dermatitis—Docetaxel—pancreatic cancer	0.000716	0.000732	CcSEcCtD
Glimepiride—Confusional state—Doxorubicin—pancreatic cancer	0.000715	0.000731	CcSEcCtD
Glimepiride—Headache—Docetaxel—pancreatic cancer	0.000712	0.000728	CcSEcCtD
Glimepiride—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000709	0.000725	CcSEcCtD
Glimepiride—Shock—Doxorubicin—pancreatic cancer	0.000698	0.000713	CcSEcCtD
Glimepiride—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000695	0.00071	CcSEcCtD
Glimepiride—Insomnia—Epirubicin—pancreatic cancer	0.000694	0.000709	CcSEcCtD
Glimepiride—Tachycardia—Doxorubicin—pancreatic cancer	0.000692	0.000708	CcSEcCtD
Glimepiride—Paraesthesia—Epirubicin—pancreatic cancer	0.000689	0.000704	CcSEcCtD
Glimepiride—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000686	0.000701	CcSEcCtD
Glimepiride—Dyspnoea—Epirubicin—pancreatic cancer	0.000684	0.000699	CcSEcCtD
Glimepiride—Somnolence—Epirubicin—pancreatic cancer	0.000682	0.000697	CcSEcCtD
Glimepiride—Anorexia—Doxorubicin—pancreatic cancer	0.000676	0.000691	CcSEcCtD
Glimepiride—Nausea—Docetaxel—pancreatic cancer	0.000675	0.00069	CcSEcCtD
Glimepiride—Dyspepsia—Epirubicin—pancreatic cancer	0.000675	0.00069	CcSEcCtD
Glimepiride—Decreased appetite—Epirubicin—pancreatic cancer	0.000667	0.000681	CcSEcCtD
Glimepiride—Hypotension—Doxorubicin—pancreatic cancer	0.000663	0.000677	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000662	0.000676	CcSEcCtD
Glimepiride—Fatigue—Epirubicin—pancreatic cancer	0.000661	0.000676	CcSEcCtD
Glimepiride—Insomnia—Doxorubicin—pancreatic cancer	0.000642	0.000656	CcSEcCtD
Glimepiride—Paraesthesia—Doxorubicin—pancreatic cancer	0.000637	0.000651	CcSEcCtD
Glimepiride—Dyspnoea—Doxorubicin—pancreatic cancer	0.000633	0.000646	CcSEcCtD
Glimepiride—Feeling abnormal—Epirubicin—pancreatic cancer	0.000632	0.000646	CcSEcCtD
Glimepiride—Somnolence—Doxorubicin—pancreatic cancer	0.000631	0.000645	CcSEcCtD
Glimepiride—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000627	0.000641	CcSEcCtD
Glimepiride—Dyspepsia—Doxorubicin—pancreatic cancer	0.000625	0.000638	CcSEcCtD
Glimepiride—Decreased appetite—Doxorubicin—pancreatic cancer	0.000617	0.00063	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000613	0.000626	CcSEcCtD
Glimepiride—Fatigue—Doxorubicin—pancreatic cancer	0.000612	0.000625	CcSEcCtD
Glimepiride—Urticaria—Epirubicin—pancreatic cancer	0.000609	0.000622	CcSEcCtD
Glimepiride—Abdominal pain—Epirubicin—pancreatic cancer	0.000606	0.000619	CcSEcCtD
Glimepiride—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000585	0.000597	CcSEcCtD
Glimepiride—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.00058	0.000593	CcSEcCtD
Glimepiride—Hypersensitivity—Epirubicin—pancreatic cancer	0.000565	0.000577	CcSEcCtD
Glimepiride—Urticaria—Doxorubicin—pancreatic cancer	0.000564	0.000576	CcSEcCtD
Glimepiride—Abdominal pain—Doxorubicin—pancreatic cancer	0.000561	0.000573	CcSEcCtD
Glimepiride—Asthenia—Epirubicin—pancreatic cancer	0.00055	0.000562	CcSEcCtD
Glimepiride—Pruritus—Epirubicin—pancreatic cancer	0.000542	0.000554	CcSEcCtD
Glimepiride—Diarrhoea—Epirubicin—pancreatic cancer	0.000525	0.000536	CcSEcCtD
Glimepiride—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000523	0.000534	CcSEcCtD
Glimepiride—Asthenia—Doxorubicin—pancreatic cancer	0.000509	0.00052	CcSEcCtD
Glimepiride—Dizziness—Epirubicin—pancreatic cancer	0.000507	0.000518	CcSEcCtD
Glimepiride—Pruritus—Doxorubicin—pancreatic cancer	0.000502	0.000513	CcSEcCtD
Glimepiride—Vomiting—Epirubicin—pancreatic cancer	0.000488	0.000498	CcSEcCtD
Glimepiride—Diarrhoea—Doxorubicin—pancreatic cancer	0.000485	0.000496	CcSEcCtD
Glimepiride—Rash—Epirubicin—pancreatic cancer	0.000483	0.000494	CcSEcCtD
Glimepiride—Dermatitis—Epirubicin—pancreatic cancer	0.000483	0.000494	CcSEcCtD
Glimepiride—Headache—Epirubicin—pancreatic cancer	0.00048	0.000491	CcSEcCtD
Glimepiride—Dizziness—Doxorubicin—pancreatic cancer	0.000469	0.000479	CcSEcCtD
Glimepiride—Nausea—Epirubicin—pancreatic cancer	0.000455	0.000465	CcSEcCtD
Glimepiride—Vomiting—Doxorubicin—pancreatic cancer	0.000451	0.000461	CcSEcCtD
Glimepiride—Rash—Doxorubicin—pancreatic cancer	0.000447	0.000457	CcSEcCtD
Glimepiride—Dermatitis—Doxorubicin—pancreatic cancer	0.000447	0.000457	CcSEcCtD
Glimepiride—Headache—Doxorubicin—pancreatic cancer	0.000444	0.000454	CcSEcCtD
Glimepiride—Nausea—Doxorubicin—pancreatic cancer	0.000421	0.000431	CcSEcCtD
